Farther Finance Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.7K Sell
139
-45
-24% -$13K ﹤0.01% 3187
2025
Q4
$55.8K Buy
184
+80
+77% +$25K ﹤0.01% 2746
2025
Q3
$29.2K Buy
104
+36
+53% +$9.8K ﹤0.01% 2787
2025
Q2
$16.4K Buy
68
+10
+17% +$2.36K ﹤0.01% 2802
2025
Q1
$13.9K Sell
58
-58
-50% -$17.4K ﹤0.01% 2577
2024
Q4
$38.1K Sell
116
-11
-9% -$3.73K ﹤0.01% 1791
2024
Q3
$42.5K Buy
127
+26
+26% +$8.26K ﹤0.01% 1741
2024
Q2
$26.7K Sell
101
-51
-34% -$14.8K ﹤0.01% 1669
2024
Q1
$51.5K Buy
152
+41
+37% +$13.5K ﹤0.01% 1181
2023
Q4
$35.8K Buy
111
+32
+41% +$10K ﹤0.01% 1147
2023
Q3
$28.3K Sell
79
-22
-22% -$8.49K ﹤0.01% 985
2023
Q2
$38.3K Buy
101
+30
+42% +$12.2K 0.01% 751
2023
Q1
$34K Buy
71
+13
+22% +$6.09K 0.01% 726
2022
Q4
$24.4K Buy
+58
New +$23.4K 0.01% 671

Other funds holding BIO